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Abstract
Background: Recent evidence suggests a two-way interaction between the immune and circadian systems. Circadian 
control of immune factors, as well as the effect of immunological variables on circadian rhythms, might be key 
elements in both physiological and pathological responses to the environment. Among these relevant factors, 
galectin-1 is a member of a family of evolutionarily-conserved glycan-binding proteins with both extracellular and 
intracellular effects, playing important roles in immune cell processes and inflammatory responses. Many of these 
actions have been studied through the use of mice with a null mutation in the galectin-1 (Lgals1) gene. To further 
analyze the role of endogenous galectin-1 in vivo, we aimed to characterize the circadian behavior of galectin-1 null 
(Lgals1-/-) mice.
Methods: We analyzed wheel-running activity in light-dark conditions, constant darkness, phase responses to light 
pulses (LP) at circadian time 15, and reentrainment to 6 hour shifts in light-dark schedule in wild-type (WT) and Lgals1-
/- mice.
Results: We found significant differences in free-running period, which was longer in mutant than in WT mice (24.02 vs 
23.57 h, p < 0.005), phase delays in response to LP (2.92 vs 1.90 circadian h, p < 0.05), and also in alpha (14.88 vs. 12.35 
circadian h, p < 0.05).
Conclusions: Given the effect of a null mutation on circadian period and entrainment, we indicate that galectin-1 
could be involved in the regulation of murine circadian rhythmicity. This is the first study implicating galectin-1 in the 
mammalian circadian system.
Background
Circadian systems represent an endogenous mechanism
adapted to cycling environmental conditions. In mam-
mals, the central circadian clock is located in the supra-
chiasmatic nuclei (SCN), guiding circadian-regulated
biological variables such as the sleep-wake cycle, hor-
monal secretions and locomotor activity [1]. Another
physiological process that exhibits circadian fluctuations,
with obvious implications in disease progression and out-
come, is the regulation of immune function.
The link between the circadian and the immune sys-
tems has been extensively investigated [2-4]. Circadian
rhythms within the immune system were described in
several tissues and cellular populations [5]. In humans,
the number of lymphocytes and granulocytes peaks dur-
ing the night, whereas monocytes and neutrophil levels
fall during the day [6]. Major humoral immune responses
undergo circadian changes, and rhythms in plasmatic lev-
els of pro-inflammatory cytokines, as well as peptide hor-
mones produced and secreted by immune cells, were also
reported [3,5-7].
In addition, circadian outputs might affect the central
clock through a feedback mechanism that fine-tunes the
system. The influence of the immune over the circadian
system has been studied in recent years, and there are
evidences of the effects of cytokines or chemokines in the
central nervous system (CNS) [8-13]. A growing number
of recent evidences point to the existence of a bidirec-
tional interaction between the immune and circadian sys-
tems which might be essential in the study of disease
progression and treatment. Recent work in our labora-
tory has shown that acute doses of bacterial LPS induce
phase changes in mice [4,14], probably mediated through
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Page 2 of 7NF-κB activation [15]. Moreover, cytokines activate clock
genes in CNS glial cells, which could release factors to
synchronize CNS neurons [16].
Galectins, a family of evolutionarily-conserved β-galac-
toside-binding proteins, can control a variety of biologi-
cal processes including the regulation of
neuroimmunoendocrine networks [17,18]. Galectin-1
(Gal1), a homodimeric protein of this family, can regulate
immune cell homeostasis by modulating cytokine synthe-
sis, T cell survival and dendritic cell physiology (reviewed
in [19]). Blockade of Gal1 expression within tumor tissue
results in heightened T-cell mediated tumor rejection
and increased survival of antitumor Th1 cells [20]. Recent
evidence from our laboratory provided rational explana-
tions for these selective immunosuppressive effects dem-
onstrating the ability of Gal1 to preferentially regulate the
survival of particularly glycosylated T-cell subsets [21]
and induce the amplification of tolerogenic signals deliv-
ered from dendritic cells to T cells in a paracrine circuit
involving IL-27 and IL-10 [22]. Although the major role
for Gal1 has been studied in the context of immune regu-
lation, tumor progression or inflammation [18,22-25],
recent evidence suggests that it might also play an impor-
tant role in nerve regeneration [26], muscle innervation
[27] and neurogenesis [28,29]. In fact, Gal1 is expressed
in both motor and sensory neurons [30] and modifies the
expression of neuronal NMDA glutamate receptors [31].
Galectins have been associated with several biological
processes in physiological as well as in pathological con-
ditions (reviewed in [18]); yet the direct involvement of
galectins in animal behavior is largely unexplored.
Based on the evidence that several cytokines and
immune factors are known to affect circadian
rhythms[13,14,32-34], we wished to explore whether the
individual functions of Gal1 displayed on different bio-
logical settings, may influence or compromise behavioral
parameters. The aim of this study is to establish a role for
Gal1 in the mammalian circadian system, by characteriz-
ing the circadian activity behavior of the Gal1 null mutant
(Lgals1-/-) [35].
Methods
Animals
Lgals1-/- mice (C57BL/6J) were generated by F.P. at the
Jacques Monod Institute (Paris), and were bred at the
Animal facilities of the Faculty of Exact and Natural Sci-
ences (University of Buenos Aires) and the Institute of
Biology and Experimental Medicine (CONICET). Male
mutants (n = 5) and male littermate wild-type mice (n =
4) were kept and manipulated according to the NIH
Guide for the Care and Use of Laboratory Animals. The
experimental protocol was approved by our institutional
research committee. At 90 days of age, mice were placed
in individual cages provided with a 17-cm running wheel,
under a 12:12 light-dark schedule (LD), with water and
food ad libitum. Mice were kept in constant darkness
(DD) in order to characterize the endogenous circadian
period.
Wheel-running locomotor activity recording
Wheel-running activity was constantly monitored by a
digital system (Archron, Argentina) which recorded the
number of wheel revolutions every 5 minutes. Activity
phase onset was taken as circadian time 12 (CT12). Light
pulses (> 300 lux) were administered at CT 15 for the
analysis of phase delays.
For reentrainment experiments, animals were initially
maintained under a 12:12-h light-dark cycle (LD) for at
least 10 days. Then, mice were subjected to an abrupt 6-h
delay or advance in the phase of the LD cycle by shorten-
ing (for advances) or lengthening (for delays) the night
previous to the shift. Time for reentrainment to the new
LD cycle was defined as the time it took for each animal
to adjust its activity onset with the new cycle according to
the phase angle of the onset on the original LD scheme.
Data analysis
All data presented is expressed as mean ± SEM. Activity
data was analyzed using the tools included in El Temps
software (Antoni Díez Noguera, University of Barcelona).
Free-running activity periods were determined by Chi-
square periodograms. To analyze alpha (the time devoted
to nocturnal locomotion) and phase angle (the difference
between activity onset and the time of lights off ), mean
waveforms were obtained from the activity recordings in
the free-running interval and the "activity" period (alpha)
was defined as the area of the curve on top of the median
of activity. The area under the curve was calculated to
analyze amplitude and activity concentration; amplitude
was defined as the percent of total activity represented in
the activity period, and concentration of activity was cal-
culated as the ratio of this percent to alpha. In order to
achieve a correct analysis of activity patterns, each indi-
vidual waveform was built from relative activity data,
obtained by determining the ratio of absolute activity
counts to average counts in the analyzed period for each
animal; this is later referred to as "Relative activity".
Activity onset on each individual day was defined as the
first 5-min bin that contained at least 80 wheel revolu-
tions, followed by another bin of at least 80 wheel revolu-
tions within 40 min. Phase shifts were calculated by
measuring the phase difference between eye-fitted
regression lines through 4-6 consecutive activity onset
times immediately prior to the light pulse, and at least 10
consecutive activity onset times after the light pulse
(excluding the 5 cycles immediately after the pulse) [36].
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In classical behavioral tests, both wild-type and Lgals1-/-
mice exhibited normal entrainment to LD cycles, with a
small but significant difference in phase angle: WT ani-
mals tended to start their locomotor activity before lights
off while mutants presented their activity onset after ZT
12 (p < 0.05, Student's t test, Table 1). Upon transfer to
DD conditions, the endogenous period of wheel-running
activity was determined. Significant differences were
found between circadian period for both groups; for WT
mice, mean period was 23.57 ± 0.10 h, while for Lgals1-/-
mice was 24.02 ± 0.03 h (p = 0.002, Student's t test).
The length of the activity interval (i.e., alpha) was
found to be significantly different between mutants and
WT mice. Alpha for mutants was 14.88 ± 0.88 circadian
hours while it was 12.35 ± 0.38 circadian hours for WT
mice (p < 0.05, Student's t test). Amplitude was found to
be similar in both groups, as activity intervals repre-
sented 97% of total activity. In consequence, the amount
of activity as related to the total time spent in the activity
interval was significantly higher in WT animals as com-
pared to mutants. All data is summarized in Table 1, and
representative actograms of both groups are shown in
Fig. 1. A tendency towards a bimodal pattern in locomo-
tor activity can be seen in mutant mice, although a three-
block analysis of alpha revealed no significant differences
between groups (Fig. 2).
Phase delays in response to light pulses at CT15 were
significantly larger for mutant mice (2.92 ± 0.26 circadian
h) than for WT animals (1.90 ± 0.34 circadian h) (p <
0.05, Student's t test). Data is summarized in Table 1 and
representative actograms are shown in Fig. 1.
No significant differences were found between the
groups for reentrainment to a phase delay or phase
advance in the LD cycle. After a 6-h advance of the LD
cycle, WT animals took 8.7 ± 0.3 days and mutants
needed 8.2 ± 0.4 days for reentrainment. After 6-h delays
the corresponding figures were 2.0 ± 0.6 and 2.4 ± 0.4
Table 1: Wheel-running activity recordings. Both alpha and phase shifts indicated are calculated relative to endogenous 
free-running period.
Group P
Wild-type Mutants
Alpha in LD (h) 11.35 ± 0.62 12.12 ± 0.21 ns
Phase angle in LD (min) -49 ± 23.15 9.4 ± 2.92 0.04
Free-running period (h)
Before light pulse 23.57 ± 0.11 23.93 ± 0.03† 0.01
After light pulse 23.57 ± 0.10 24.02 ± 0.03† 0.002
Alpha in DD (circadian h) 12.35 ± 0.38 14.88 ± 0.88 0.04
Amplitude in DD (%) 97.3 ± 0.9 97.4 ± 0.5 ns
Amplitude/Alpha (%/h) 7.90 ± 0.27 6.62 ± 0.35 0.03
Phase delays in response to LP at CT15 
(circadian h)
1.90 ± 0.34 2.92 ± 0.26 0.04
Reentrainment to 6 h advance of LD 
cycle (days)
8.7 ± 0.3 8.2 ± 0.4 ns
Reentrainment to 6 h delay (days) 2.0 ± 0.6 2.4 ± 0.4 ns
Phase angle in LD refers to the difference between the time of lights off and activity onset (negative values indicate animals start running 
before lights off). All data are expressed as Mean ± SEM. P values correspond to Student's t test. † Difference between these two results is not 
significant according to paired t test analysis.
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found for both WT and mutant mice when subjected to
light stimulation at CT21, without any significant differ-
ence between them (data not shown).
Discussion
According to our results, a deficit in Gal1 expression
induces subtle, albeit significant, changes in the circadian
behavior of mice. Mutant animals exhibited a longer cir-
cadian period and, as expected after this result, a larger
phase delay response to light pulses (according to the
phase response curve of mice; larger phase delays would
allow animals with a longer endogenous period to entrain
to a 24-h LD cycle). However, the similarities between
reentrainment rate between mutant and WT animals
suggest that Gal1 might act on a non-parametric photic
mechanism (i.e., the response to light pulses) rather than
a parametric effect, such as a complete photoperiod syn-
chronization.
In addition, we have preliminary evidence for Gal-1
expression in the suprachiasmatic region of control mice,
which was absent in knockout animals (see additional File
1: Immunohistochemical analysis of Gal-1 in the supra-
chiasmatic area). Indeed, the expression of Gal1 in the
suprachiasmatic nuclei (SCN) region of the CNS would
suggest that this factor might be implicated in both the
generation and the entrainment of circadian rhythms. It
is tempting to speculate that the lack of Gal1 might affect
the normal development of SCN neurons, as has been
found for other CNS areas such as the olfactory bulb [37-
39]. It is possible that small structural differences along
neural developmental may elicit changes in the adult cir-
cadian behavior and responses to light.
Moreover, Gal1 expression in glial cells [28,29,40,41]
provides an additional substrate for immune-related
effects on circadian responses, since glial cells have been
implicated in the generation and modulation of circadian
rhythms [16,42]. In particular, astrocytic-derived Gal1
Figure 1 Representative actograms of a) WT and b) Lgals1-/-  type mice. Stars indicate day and time of light pulses at CT15. Clear differences in 
free-running period and alpha can be appreciated (see Table 1). Moreover, after light pulse at CT 15 (i.e., 3 hours after activity onset under DD), a larger 
phase delay can be seen in Lgals1-/- mice (see Table 1 for details).
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icity by altering the expression of NMDA receptors [31],
which are key actors in the signal transduction pathway
for circadian responses to light [43]. Moreover, changes
in these receptors, present in the retinorecipient portion
of the SCN and responsive to photic stimulation, might
explain at least in part the variation in light-induced
phase shifts in the mutants.
Conclusions
The differences reported for circadian period and light-
induced phase delays in Gal1 mutants should also be
taken into account when employing this model in
immune or behavioral research. Further research of daily
or circadian fluctuations in specific immune variables
should be performed in order to establish the possible
implications of Gal1 in the mammalian circadian system.
To illustrate this concept, Gal1-mediated tolerogenic
mechanisms, including promotion of T cell apoptosis,
modulation of Th2 cytokine balance or the control of
dendritic cell physiology may be selectively influenced by
the circadian system. This implies caution in the moni-
toring of these immunoregulatory effects which may sub-
stantially fluctuate during the light-dark cycle. In
conclusion, we provide the first evidence of alterations in
the behavior of mice devoid of Gal1, which prompts fur-
ther investigation of the relevance of this endogenous
protein in physiopathological processes.
Figure 2 a) Average amount of relative activity (see Methods for details) during each third of alpha, as determined from individual relative 
activity waveforms under free running conditions. b) Average waveforms for each group, adjusted to tau period. Time point 0 represents CT12. 
All error bars represent mean ± SEM.
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